JPMorgan Chase & Co’s EyePoint Pharmaceuticals EYPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.33M | Sell |
247,412
-147,933
| -37% | -$1.39M | ﹤0.01% | 3235 |
|
|
2025
Q1 | $2.14M | Sell |
395,345
-99
| -0% | -$537 | ﹤0.01% | 3212 |
|
|
2024
Q4 | $2.95M | Buy |
395,444
+23,686
| +6% | +$176K | ﹤0.01% | 3149 |
|
|
2024
Q3 | $2.97M | Buy |
371,758
+342,516
| +1,171% | +$2.74M | ﹤0.01% | 2983 |
|
|
2024
Q2 | $254K | Buy |
29,242
+1,621
| +6% | +$14.1K | ﹤0.01% | 4157 |
|
|
2024
Q1 | $571K | Buy |
27,621
+2,956
| +12% | +$61.1K | ﹤0.01% | 3889 |
|
|
2023
Q4 | $570K | Sell |
24,665
-583,825
| -96% | -$13.5M | ﹤0.01% | 3834 |
|
|
2023
Q3 | $4.86M | Buy |
608,490
+587,285
| +2,770% | +$4.69M | ﹤0.01% | 2453 |
|
|
2023
Q2 | $184K | Buy |
21,205
+337
| +2% | +$2.93K | ﹤0.01% | 4316 |
|
|
2023
Q1 | $62K | Buy |
20,868
+5,217
| +33% | +$15.5K | ﹤0.01% | 4830 |
|
|
2022
Q4 | $55K | Sell |
15,651
-829
| -5% | -$2.91K | ﹤0.01% | 4710 |
|
|
2022
Q3 | $131K | Buy |
16,480
+1,033
| +7% | +$8.21K | ﹤0.01% | 4356 |
|
|
2022
Q2 | $122K | Sell |
15,447
-283
| -2% | -$2.24K | ﹤0.01% | 4549 |
|
|
2022
Q1 | $191K | Buy |
15,730
+4,578
| +41% | +$55.6K | ﹤0.01% | 4471 |
|
|
2021
Q4 | $136K | Buy |
11,152
+2,988
| +37% | +$36.4K | ﹤0.01% | 4708 |
|
|
2021
Q3 | $86K | Sell |
8,164
-23,054
| -74% | -$243K | ﹤0.01% | 4781 |
|
|
2021
Q2 | $281K | Buy |
31,218
+31,098
| +25,915% | +$280K | ﹤0.01% | 4321 |
|
|
2021
Q1 | $1K | Buy |
120
+100
| +500% | +$833 | ﹤0.01% | 5192 |
|
|
2020
Q4 | $0 | Sell |
20
-2
| -9% | – | ﹤0.01% | 4936 |
|
|
2020
Q3 | $0 | Buy |
22
+4
| +22% | – | ﹤0.01% | 4844 |
|
|
2020
Q2 | $0 | Sell |
18
-8,187
| -100% | – | ﹤0.01% | 4790 |
|
|
2020
Q1 | $84K | Buy |
8,205
+6,167
| +303% | +$63.1K | ﹤0.01% | 3991 |
|
|
2019
Q4 | $31K | Buy |
2,038
+8
| +0.4% | +$122 | ﹤0.01% | 4352 |
|
|
2019
Q3 | $37K | Buy |
2,030
+330
| +19% | +$6.02K | ﹤0.01% | 4344 |
|
|
2019
Q2 | $28K | Buy |
+1,700
| New | +$28K | ﹤0.01% | 4451 |
|
|
2018
Q4 | – | Sell |
-14,357
| Closed | -$513K | – | 4875 |
|
|
2018
Q3 | $513K | Sell |
14,357
-23,194
| -62% | -$829K | ﹤0.01% | 3478 |
|
|
2018
Q2 | $781K | Buy |
+37,551
| New | +$781K | ﹤0.01% | 3251 |
|
|
2017
Q4 | – | Sell |
-80
| Closed | -$1K | – | 4674 |
|
|
2017
Q3 | $1K | Sell |
80
-2,104
| -96% | -$26.3K | ﹤0.01% | 4237 |
|
|
2017
Q2 | $37K | Buy |
2,184
+743
| +52% | +$12.6K | ﹤0.01% | 3800 |
|
|
2017
Q1 | $25K | Sell |
1,441
-389
| -21% | -$6.75K | ﹤0.01% | 4074 |
|
|
2016
Q4 | $31K | Buy |
+1,830
| New | +$31K | ﹤0.01% | 4093 |
|